Unimed and Zeino Pharma join forces to bring innovative pharmaceutical solutions to the UAE

UNIMED, a leading healthcare solutions provider in the UAE, has signed a strategic distribution agreement with Zeino Pharma at Arab Health 2025. This collaboration will introduce innovative pharmaceutical solutions to the UAE market, ensuring patients receive cutting-edge treatments that enhance their well-being.

Through this agreement, UNIMED will distribute Zeino Pharma’s advanced medications, which are designed to address key healthcare challenges and improve patient outcomes.

"At UNIMED, we strive to provide patients with the most advanced, high-quality, and accessible pharmaceutical products," said Ahmad Jarrar, General Manager of UNIMED. "Partnering with Zeino Pharma enables us to bring groundbreaking solutions to the UAE, elevating the standard of care for patients across the region."

"At Zeino Pharma, we are committed to pioneering innovative pharmaceuticals that set new standards in patient care and improve health outcomes," said Mohammad Shujaa Assaleh, Commercial & Marketing Manager at Zeino Pharma.

The agreement was signed during Arab Health 2025, reinforcing UNIMED’s dedication to driving healthcare innovation in the UAE.